NCT01747291

Brief Summary

Osteoporosis is a disease characterized by increased bone fragility and deteriorating bone micro-architecture. The main consequence of osteoporosis is low-trauma fractures, most often of the hip, spine and wrist. Recently, another type of low-trauma fracture, atypical femur fractures (AFFs), have received much attention. Little is known of the cause of these debilitating fractures; however, they have been associated with long term bisphosphonate use. What we currently know about AFFs is based on case reports or small case series, or studies using administrative databases or secondary analyses of bisphosphonate trials. While these reports provide some preliminary information on the relationship between long term bisphosphonate exposure and AFFs, detailed clinical data are absent. As we have established a network of specialists across southern Ontario our group is in a position to collect meaningful information on a larger group of patients who have experienced these debilitating fractures into a centralized AFF registry.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Jun 2009

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Jun 2009Dec 2026

Study Start

First participant enrolled

June 1, 2009

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

December 7, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 11, 2012

Completed
13 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

May 23, 2023

Status Verified

May 1, 2023

Enrollment Period

16.5 years

First QC Date

December 7, 2012

Last Update Submit

May 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prospectively identify and diagnose atypical fracture patients in Ontario

    The objective of this exploratory study is to identify and diagnose AFF patients

    baseline

Secondary Outcomes (1)

  • Examine risk factors and predictors for AFFs

    baseline

Other Outcomes (1)

  • Examine how AFFs affect quality of life, functional recovery and health outcomes.

    baseline and every 6-12 months

Study Arms (1)

Atypical femur fracture cohort

Eligibility Criteria

Age20 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

primary or tertiary care clinic patients who have experienced an atypical fracture at any point in the past will be eligible for this observational study. Low trauma fractures are defined as fractures sustained with minimal force, such as a fall from standing height.

You may qualify if:

  • Patients over the age of 20;
  • Patients who have experienced an incomplete AFF that satisfies the diagnostic criteria as set forth by the American Society of Bone and mineral Research (ASBMR) International Task Force on AFFs or a low (or no) trauma fracture that mimics the features described above at other sites.

You may not qualify if:

  • Peri-prosthetic fractures;
  • High trauma fractures;
  • Pathological fractures secondary to metastases or metabolic bone diseases other than osteoporosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

McMaster University

Hamilton, Ontario, Canada

ENROLLING BY INVITATION

University Health Network

Toronto, Ontario, M5G 2C4, Canada

RECRUITING

St Michael's Hospital

Toronto, Ontario, Canada

ENROLLING BY INVITATION

Study Officials

  • Angela m Cheung, MD, PhD

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Judite Scher, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2012

First Posted

December 11, 2012

Study Start

June 1, 2009

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

May 23, 2023

Record last verified: 2023-05

Locations